Profile data is unavailable for this security.
About the company
Medtronic plc is a global healthcare technology company. It develops, manufactures, and markets its medical devices and technologies to hospitals, physicians, clinicians, and patients. Its operating segments include Cardiovascular, Medical Surgical, Neuroscience and Diabetes. Cardiovascular products include pacemakers, insertable cardiac monitors, and cardiac resynchronization therapy devices. Medical Surgical products include patient care from diagnosis to recovery, with a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications. Neuroscience products include various spinal implants, bone graft substitutes, biologic products, image-guided surgery and intra-operative imaging systems. Diabetes products include insulin pumps, continuous glucose monitoring (CGM) systems, consumables, and smart insulin pen systems. The Company also provides PROPEL and SINUVA, which is bioabsorbable, steroid-eluting implants for sinus patients.
- Revenue in USD (TTM)31.69bn
- Net income in USD5.04bn
- LocationMedtronic PLC20 On Hatch, Hatch Street LowerDUBLIN 2IrelandIRL
- Phone+353 14381700
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|MDT:NYQ since |
|Cathworks Ltd||Announced||12 Jul 2022||12 Jul 2022Announced||6.58%||--|
|Acutus Medical Inc-Left-Heart Access Portfolio||Deal completed||27 Apr 2022||27 Apr 2022Deal completed||-11.22%||87.00m|
|Affera Inc||Announced||10 Jan 2022||10 Jan 2022Announced||-9.85%||--|
|Triple Jump Israel Ltd||Rumoured||17 Oct 2021||17 Oct 2021Rumoured||-25.79%||--|